Raises 2026 revenue guidance to $360M-$370M and Adj. EBITDA to $50M-$54M

Flotek Industries has once again increased its financial outlook for the full year 2026. This marks the second upward revision to guidance in the current year, following a previous update on August 4, 2026. The company now anticipates total revenue for 2026 to be between $360 million and $370 million, up from the prior range of $340 million to $350 million. Similarly, Adjusted EBITDA guidance has been raised to a range of $50 million to $54 million, an increase from the previous $47 million to $51 million.

The updated guidance reflects stronger than anticipated performance in international chemistry sales. The company reported international chemistry revenue of approximately $10.6 million in the second quarter of 2026, which represents a sequential increase of more than 450% from the first quarter. This growth is significantly driven by ongoing work in Saudi Arabia.

Flotek expects this trend to continue, projecting that international chemistry sales will exceed $40 million during the second half of 2026. The company’s Chief Executive Officer, Dr. Ryan Ezell, highlighted sustained demand for Flotek's data and chemistry technologies and strong customer response to their solutions as key drivers. The revised midpoints of the 2026 guidance ranges would represent a 54% increase in total revenue and a 58% increase in Adjusted EBITDA compared to the full-year 2025 metrics.

The filing does not provide updated guidance for segments beyond total revenue and Adjusted EBITDA, nor does it detail specific changes to domestic chemistry sales or other operational metrics that contribute to the overall revised outlook.